• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型构象依赖性 Tau 抗体受相邻磷酸化位点调节。

Novel Conformation-Dependent Tau Antibodies Are Modulated by Adjacent Phosphorylation Sites.

机构信息

Department of Neuroscience, College of Medicine, University of Florida, Gainesville, FL 32610, USA.

Center for Translational Research in Neurodegenerative Disease, College of Medicine, University of Florida, Gainesville, FL 32610, USA.

出版信息

Int J Mol Sci. 2023 Sep 5;24(18):13676. doi: 10.3390/ijms241813676.

DOI:10.3390/ijms241813676
PMID:37761979
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10530490/
Abstract

Tau proteins within the adult central nervous system (CNS) are found to be abnormally aggregated into heterogeneous filaments in neurodegenerative diseases, termed tauopathies. These tau inclusions are pathological hallmarks of Alzheimer's disease (AD), Pick's disease (PiD), corticobasal degeneration (CBD), and progressive supranuclear palsy (PSP). The neuropathological hallmarks of these diseases burden several cell types within the CNS, and have also been shown to be abundantly phosphorylated. The mechanism(s) by which tau aggregates in the CNS is not fully known, but it is hypothesized that hyperphosphorylated tau may precede and further promote filament formation, leading to the production of these pathological inclusions. In the studies herein, we generated and thoroughly characterized two novel conformation-dependent tau monoclonal antibodies that bind to residues Pro218-Glu222, but are sensitive to denaturing conditions and highly modulated by adjacent downstream phosphorylation sites. These epitopes are present in the neuropathological hallmarks of several tauopathies, including AD, PiD, CBD, and PSP. These novel antibodies will further enable investigation of tau-dependent pathological inclusion formation and enhance our understanding of the phosphorylation signatures within tauopathies with the possibility of new biomarker developments.

摘要

在神经退行性疾病中,成年中枢神经系统(CNS)中的 Tau 蛋白被发现异常聚集到异质纤维中,称为 Tau 病。这些 Tau 包含物是阿尔茨海默病(AD)、匹克氏病(PiD)、皮质基底节变性(CBD)和进行性核上性麻痹(PSP)的病理学特征。这些疾病的神经病理学特征在 CNS 中的几种细胞类型中存在,并且已经被证明大量磷酸化。 Tau 在 CNS 中聚集的机制尚不完全清楚,但据推测,过度磷酸化的 Tau 可能先于并进一步促进纤维形成,导致这些病理性包含物的产生。在本研究中,我们生成并彻底表征了两种新型构象依赖性 Tau 单克隆抗体,它们与残基 Pro218-Glu222 结合,但对变性条件敏感,并受相邻下游磷酸化位点高度调节。这些表位存在于几种 Tau 病的神经病理学特征中,包括 AD、PiD、CBD 和 PSP。这些新型抗体将进一步促进 Tau 依赖性病理性包含物形成的研究,并增强我们对 Tau 病中磷酸化特征的理解,有可能开发新的生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3435/10530490/88ad07b585fb/ijms-24-13676-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3435/10530490/6668d23e0e13/ijms-24-13676-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3435/10530490/2bcdb00a9a59/ijms-24-13676-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3435/10530490/40433ac58271/ijms-24-13676-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3435/10530490/4541dddac20c/ijms-24-13676-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3435/10530490/eb00ec673297/ijms-24-13676-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3435/10530490/b31a3ed75f2a/ijms-24-13676-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3435/10530490/46a40be07a06/ijms-24-13676-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3435/10530490/88ad07b585fb/ijms-24-13676-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3435/10530490/6668d23e0e13/ijms-24-13676-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3435/10530490/2bcdb00a9a59/ijms-24-13676-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3435/10530490/40433ac58271/ijms-24-13676-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3435/10530490/4541dddac20c/ijms-24-13676-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3435/10530490/eb00ec673297/ijms-24-13676-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3435/10530490/b31a3ed75f2a/ijms-24-13676-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3435/10530490/46a40be07a06/ijms-24-13676-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3435/10530490/88ad07b585fb/ijms-24-13676-g008.jpg

相似文献

1
Novel Conformation-Dependent Tau Antibodies Are Modulated by Adjacent Phosphorylation Sites.新型构象依赖性 Tau 抗体受相邻磷酸化位点调节。
Int J Mol Sci. 2023 Sep 5;24(18):13676. doi: 10.3390/ijms241813676.
2
Detection of Alzheimer Disease (AD)-Specific Tau Pathology in AD and NonAD Tauopathies by Immunohistochemistry With Novel Conformation-Selective Tau Antibodies.使用新型构象选择性 Tau 抗体通过免疫组织化学检测 AD 和非 AD Tau 病中的 AD 特异性 Tau 病理学。
J Neuropathol Exp Neurol. 2018 Mar 1;77(3):216-228. doi: 10.1093/jnen/nly010.
3
Selective tau tyrosine nitration in non-AD tauopathies.选择性 Tau 酪氨酸硝化在非 AD Tau 病中。
Acta Neuropathol. 2012 Jan;123(1):119-32. doi: 10.1007/s00401-011-0898-8. Epub 2011 Nov 6.
4
Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.糖原合酶激酶-3与阿尔茨海默病、皮克病、进行性核上性麻痹和皮质基底节变性中的神经元和胶质细胞过度磷酸化tau蛋白沉积有关。
Acta Neuropathol. 2002 Dec;104(6):583-91. doi: 10.1007/s00401-002-0587-8. Epub 2002 Jul 13.
5
Anti-tau phospho-specific Ser262 antibody recognizes a variety of abnormal hyper-phosphorylated tau deposits in tauopathies including Pick bodies and argyrophilic grains.抗tau蛋白磷酸化特异性丝氨酸262抗体可识别多种tau蛋白病中的异常高磷酸化tau蛋白沉积物,包括Pick小体和嗜银颗粒。
Acta Neuropathol. 2002 Dec;104(6):658-64. doi: 10.1007/s00401-002-0600-2. Epub 2002 Aug 30.
6
Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies.磷酸化丝裂原活化蛋白激酶(MAPK/ERK-P)、38 kDa蛋白激酶(p38-P)、应激激活蛋白激酶(SAPK/JNK-P)和钙/钙调蛋白依赖性激酶II(CaM激酶II)在tau蛋白病的神经元和神经胶质细胞的tau沉积物中差异表达。
J Neural Transm (Vienna). 2001;108(12):1397-415. doi: 10.1007/s007020100016.
7
Function and regulation of cis P-tau in the pathogenesis and treatment of conventional and nonconventional tauopathies.顺式磷酸化tau蛋白在传统和非传统tau蛋白病发病机制及治疗中的作用与调控
J Neurochem. 2023 Sep;166(6):904-914. doi: 10.1111/jnc.15909. Epub 2023 Aug 28.
8
Distinct phosphorylation profiles of tau in brains of patients with different tauopathies.不同tau 病患者脑中 tau 的不同磷酸化谱。
Neurobiol Aging. 2021 Dec;108:72-79. doi: 10.1016/j.neurobiolaging.2021.08.011. Epub 2021 Aug 21.
9
[Neuropathology of tauopathy].[tau蛋白病的神经病理学]
Brain Nerve. 2013 Dec;65(12):1445-58.
10
Tau protein profiling in tauopathies: a human brain study.tau 蛋白在 tau 病中的特征分析:一项人脑研究。
Mol Neurodegener. 2024 Jul 19;19(1):54. doi: 10.1186/s13024-024-00741-9.

引用本文的文献

1
A novel pThr217 tau monoclonal antibody reveals neuropathological heterogeneity in tauopathies.一种新型的磷酸化苏氨酸217 tau单克隆抗体揭示了tau蛋白病中的神经病理学异质性。
Sci Rep. 2025 Jun 5;15(1):19865. doi: 10.1038/s41598-025-04291-y.

本文引用的文献

1
CSF tau phosphorylation occupancies at T217 and T205 represent improved biomarkers of amyloid and tau pathology in Alzheimer's disease.CSF 中 tau 磷酸化的 T217 和 T205 占有率代表了阿尔茨海默病中淀粉样蛋白和 tau 病理的改进生物标志物。
Nat Aging. 2023 Apr;3(4):391-401. doi: 10.1038/s43587-023-00380-7. Epub 2023 Mar 13.
2
Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer's disease.在阿尔茨海默病前驱期,对 10 种血浆磷酸化 tau 检测方法进行头对头比较。
Brain. 2023 Apr 19;146(4):1592-1601. doi: 10.1093/brain/awac333.
3
Reassessment of Neuronal Tau Distribution in Adult Human Brain and Implications for Tau Pathobiology.
重新评估成年人大脑神经元 Tau 分布及其对 Tau 病理生物学的影响。
Acta Neuropathol Commun. 2022 Jun 28;10(1):94. doi: 10.1186/s40478-022-01394-9.
4
Pathogenic tau recruits wild-type tau into brain inclusions and induces gut degeneration in transgenic SPAM mice.致病tau 招募野生型 tau 进入脑内包涵体,并在转基因 SPAM 小鼠中诱导肠道退化。
Commun Biol. 2022 May 12;5(1):446. doi: 10.1038/s42003-022-03373-1.
5
Site-Specific Cerebrospinal Fluid Tau Hyperphosphorylation in Response to Alzheimer's Disease Brain Pathology: Not All Tau Phospho-Sites are Hyperphosphorylated.针对阿尔茨海默病脑病理的部位特异性脑脊髓液 Tau 过度磷酸化:并非所有 Tau 磷酸化位点都过度磷酸化。
J Alzheimers Dis. 2022;85(1):415-429. doi: 10.3233/JAD-210677.
6
"Don't Phos Over Tau": recent developments in clinical biomarkers and therapies targeting tau phosphorylation in Alzheimer's disease and other tauopathies.“不要忽视 Tau”:阿尔茨海默病和其他 Tau 病中针对 Tau 磷酸化的临床生物标志物和治疗方法的最新进展。
Mol Neurodegener. 2021 Jun 5;16(1):37. doi: 10.1186/s13024-021-00460-5.
7
Visualization of neurofibrillary tangle maturity in Alzheimer's disease: A clinicopathologic perspective for biomarker research.阿尔茨海默病神经原纤维缠结成熟度的可视化:生物标志物研究的临床病理视角。
Alzheimers Dement. 2021 Sep;17(9):1554-1574. doi: 10.1002/alz.12321. Epub 2021 Apr 2.
8
Tau PTM Profiles Identify Patient Heterogeneity and Stages of Alzheimer's Disease.tau 修饰谱可识别患者异质性和阿尔茨海默病的阶段。
Cell. 2020 Dec 10;183(6):1699-1713.e13. doi: 10.1016/j.cell.2020.10.029. Epub 2020 Nov 13.
9
Conformation-selective tau monoclonal antibodies inhibit tau pathology in primary neurons and a mouse model of Alzheimer's disease.构象选择性 tau 单克隆抗体抑制原代神经元和阿尔茨海默病小鼠模型中的 tau 病理学。
Mol Neurodegener. 2020 Nov 4;15(1):64. doi: 10.1186/s13024-020-00404-5.
10
Evaluation of a novel immunoassay to detect p-tau Thr217 in the CSF to distinguish Alzheimer disease from other dementias.评估一种新型免疫分析法检测脑脊液中 p-tau Thr217,以区分阿尔茨海默病与其他类型痴呆。
Neurology. 2020 Dec 1;95(22):e3026-e3035. doi: 10.1212/WNL.0000000000010814. Epub 2020 Sep 24.